IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2014
Total Assets: $17.7M
Liabilities Breakdown FY2014
Total Liabilities: $3.6M
Asset Breakdown
Total Assets: $17.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.0M | 5.8% |
| Accounts Receivable | $566.3K | 3.2% |
| Inventory | $611.7K | 3.4% |
| Property, Plant & Equipment | $7.6M | 42.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $468.1K | 2.6% |
| Other Assets | $7.5M | 42.1% |
Liabilities Breakdown
Total Liabilities: $3.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $133.4K | 3.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.5M | 96.3% |